Infectious Entry of Merkel Cell Polyomavirus.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 08 11 2018
accepted: 23 12 2018
pubmed: 11 1 2019
medline: 20 11 2019
entrez: 11 1 2019
Statut: epublish

Résumé

Merkel cell polyomavirus (MCPyV) is a small, nonenveloped tumor virus associated with an aggressive form of skin cancer, Merkel cell carcinoma (MCC). MCPyV infections are highly prevalent in the human population, with MCPyV virions being continuously shed from human skin. However, the precise host cell tropism(s) of MCPyV remains unclear: MCPyV is able to replicate within a subset of dermal fibroblasts, but MCPyV DNA has also been detected in a variety of other tissues. However, MCPyV appears different from other polyomaviruses, as it requires sulfated polysaccharides, such as heparan sulfates and/or chondroitin sulfates, for initial attachment. Like other polyomaviruses, MCPyV engages sialic acid as a (co)receptor. To explore the infectious entry process of MCPyV, we analyzed the cell biological determinants of MCPyV entry into A549 cells, a highly transducible lung carcinoma cell line, in comparison to well-studied simian virus 40 and a number of other viruses. Our results indicate that MCPyV enters cells via caveolar/lipid raft-mediated endocytosis but not macropinocytosis, clathrin-mediated endocytosis, or glycosphingolipid-enriched carriers. The viruses were internalized in small endocytic pits that led the virus to endosomes and from there to the endoplasmic reticulum (ER). Similar to other polyomaviruses, trafficking required microtubular transport, acidification of endosomes, and a functional redox environment. To our surprise, the virus was found to acquire a membrane envelope within endosomes, a phenomenon not reported for other viruses. Only minor amounts of viruses reached the ER, while the majority was retained in endosomal compartments, suggesting that endosome-to-ER trafficking is a bottleneck during infectious entry.

Identifiants

pubmed: 30626687
pii: JVI.02004-18
doi: 10.1128/JVI.02004-18
pmc: PMC6401430
pii:
doi:

Substances chimiques

Antigens, Viral, Tumor 0
Heparitin Sulfate 9050-30-0
N-Acetylneuraminic Acid GZP2782OP0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

PLoS Pathog. 2011 Mar;7(3):e1001329
pubmed: 21483486
J Virol. 2011 May;85(9):4198-211
pubmed: 21345959
PLoS Pathog. 2012;8(7):e1002738
pubmed: 22910713
J Cell Biol. 1988 Dec;107(6 Pt 1):2075-86
pubmed: 2904446
Cell Host Microbe. 2010 Jun 25;7(6):509-15
pubmed: 20542254
PLoS One. 2015 Mar 24;10(3):e0122536
pubmed: 25803288
Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7333-7
pubmed: 1651501
Annu Rev Cell Dev Biol. 2012;28:337-62
pubmed: 22831642
J Virol. 2010 Jul;84(14):7064-72
pubmed: 20444890
Mol Biol Cell. 1996 Nov;7(11):1825-34
pubmed: 8930903
Prog Clin Biol Res. 1983;105:99-106
pubmed: 6304775
J Virol. 2006 Oct;80(19):9402-13
pubmed: 16973546
Nat Cell Biol. 2011 Sep 25;13(11):1305-14
pubmed: 21947079
J Virol. 2006 May;80(9):4610-22
pubmed: 16611921
Dev Cell. 2006 Jun;10(6):839-50
pubmed: 16740485
J Virol. 2013 Aug;87(16):8843-52
pubmed: 23740996
PLoS Pathog. 2014 May 29;10(5):e1004162
pubmed: 24874089
Cell. 2004 Sep 17;118(6):767-80
pubmed: 15369675
J Natl Cancer Inst. 2015 Jan 08;107(2):
pubmed: 25575646
J Cell Biol. 1980 Feb;84(2):404-20
pubmed: 6991511
J Mol Biol. 1980 Sep 25;142(3):439-54
pubmed: 7463480
PLoS Pathog. 2009 Mar;5(3):e1000363
pubmed: 19325891
J Biol Chem. 1991 Sep 15;266(26):17707-12
pubmed: 1832676
Nat Cell Biol. 2009 May;11(5):510-20
pubmed: 19404330
Cell. 2007 Nov 2;131(3):516-29
pubmed: 17981119
Viruses. 2016 Aug 29;8(9):
pubmed: 27589785
Annu Rev Biochem. 2010;79:803-33
pubmed: 20196649
Nat Rev Microbiol. 2013 Apr;11(4):264-76
pubmed: 23474680
J Gen Virol. 2017 Jun;98(6):1159-1160
pubmed: 28640744
Science. 2002 Apr 19;296(5567):535-9
pubmed: 11964480
J Biol Chem. 1997 Jan 10;272(2):843-51
pubmed: 8995372
Traffic. 2007 Apr;8(4):389-401
pubmed: 17394486
J Virol. 2002 Sep;76(18):9368-77
pubmed: 12186919
J Cell Biol. 1989 Dec;109(6 Pt 1):2721-9
pubmed: 2556405
Annu Rev Biochem. 2009;78:857-902
pubmed: 19317650
Curr Top Microbiol Immunol. 2005;291:43-60
pubmed: 15981459
J Biol Chem. 1988 Dec 5;263(34):18545-52
pubmed: 3192548
PLoS Pathog. 2012;8(4):e1002657
pubmed: 22536154
Virus Res. 2007 Mar;124(1-2):226-30
pubmed: 17112617
Virology. 1962 May;17:65-75
pubmed: 13889129
PLoS Pathog. 2009 Sep;5(9):e1000578
pubmed: 19750217
J Cell Biol. 1979 Dec;83(3):657-62
pubmed: 574873
J Cell Biol. 2005 Jan 31;168(3):465-76
pubmed: 15668297
J Biol Chem. 1996 Feb 2;271(5):2627-33
pubmed: 8576232
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7
pubmed: 18812503
J Virol. 2005 Mar;79(5):2839-46
pubmed: 15709003
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):96-100
pubmed: 8552683
J Virol. 2002 May;76(10):5156-66
pubmed: 11967331
J Virol. 2013 Aug;87(16):9173-88
pubmed: 23760247
Science. 2008 Feb 22;319(5866):1096-100
pubmed: 18202256
PLoS Pathog. 2009 Feb;5(2):e1000318
pubmed: 19247434
Lancet. 2002 Feb 9;359(9305):497-8
pubmed: 11853800
J Surg Oncol. 2005 Jan 1;89(1):1-4
pubmed: 15611998
Adv Cancer Res. 2010;106:1-51
pubmed: 20399955
J Biol Chem. 1994 Apr 8;269(14):10706-12
pubmed: 8144660
J Virol. 2015 Jul;89(14):7038-52
pubmed: 25926655
J Virol. 2004 Nov;78(21):11583-90
pubmed: 15479799
EMBO J. 2003 Sep 1;22(17):4346-55
pubmed: 12941687
Curr Protoc Cell Biol. 2007 Dec;Chapter 26:Unit 26.1
pubmed: 18228512
Methods Mol Biol. 2014;1174:19-46
pubmed: 24947372
Methods Enzymol. 1991;201:477-82
pubmed: 1943774
J Cell Biol. 1981 Dec;91(3 Pt 1):601-13
pubmed: 7328111
Traffic. 2003 Nov;4(11):724-38
pubmed: 14617356
Dev Cell. 2002 Apr;2(4):411-23
pubmed: 11970892
Cell. 1987 Jul 31;50(3):453-63
pubmed: 3111717
J Invest Dermatol. 2007 Sep;127(9):2100-3
pubmed: 17700621
J Virol. 2000 Mar;74(5):2288-92
pubmed: 10666259
Lancet. 1971 Jun 19;1(7712):1257-60
pubmed: 4104715
J Clin Invest. 2011 Sep;121(9):3623-34
pubmed: 21841310
Cell Host Microbe. 2016 Jun 8;19(6):775-87
pubmed: 27212661
Annu Rev Pathol. 2012;7:123-44
pubmed: 21942528
J Biol Chem. 1987 Apr 25;262(12):5592-5
pubmed: 3106339
Cell Host Microbe. 2010 Oct 21;8(4):309-19
pubmed: 20951965
J Biol Chem. 1994 May 27;269(21):14869-71
pubmed: 8195116
PLoS Pathog. 2017 May 2;13(5):e1006308
pubmed: 28464022
J Virol. 2011 Mar;85(5):2386-96
pubmed: 21159867
Nat Cell Biol. 2001 May;3(5):473-83
pubmed: 11331875
J Gen Virol. 2003 Jun;84(Pt 6):1499-1504
pubmed: 12771419
Mol Cell. 2001 Mar;7(3):661-71
pubmed: 11463390
Cell. 2011 Aug 5;146(3):471-84
pubmed: 21816279
Nature. 1988 Jun 2;333(6172):426-31
pubmed: 3374584
J Virol. 2019 Mar 5;93(6):
pubmed: 30626687
Virology. 2013 Jan 5;435(1):118-30
pubmed: 23217622
Nat Cell Biol. 2010 Jan;12(1):11-8; sup pp 1-12
pubmed: 20023649
Infect Agent Cancer. 2015 Oct 19;10:35
pubmed: 26483848
Annu Rev Immunol. 1999;17:593-623
pubmed: 10358769
PLoS Pathog. 2011 Jul;7(7):e1002161
pubmed: 21829355
PLoS One. 2012;7(7):e42181
pubmed: 22860078
Cell Rep. 2017 Oct 31;21(5):1169-1179
pubmed: 29091757
Proc Soc Exp Biol Med. 1953 Jun;83(2):414-21
pubmed: 13064287
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21690215
J Cell Biol. 2010 Feb 22;188(4):547-63
pubmed: 20156964
Virology. 2012 Jun 20;428(1):30-40
pubmed: 22516137
Acta Crystallogr F Struct Biol Commun. 2018 Aug 1;74(Pt 8):451-462
pubmed: 30084394
J Gen Physiol. 1976 Jan;67(1):91-112
pubmed: 1460
J Virol. 2018 Jan 30;92(4):
pubmed: 29167345
EMBO J. 1992 May;11(5):1717-22
pubmed: 1582407
Cell Biol Int Rep. 1980 Dec;4(12):1125-9
pubmed: 7460026
PLoS Pathog. 2009 Jun;5(6):e1000465
pubmed: 19503604
J Biol Chem. 1999 Dec 17;274(51):36267-73
pubmed: 10593915
PLoS Biol. 2005 Jul;3(7):e233
pubmed: 15954801
Biochem J. 1988 Nov 15;256(1):283-90
pubmed: 2851982
Cell Microbiol. 2013 Nov;15(11):1818-36
pubmed: 23601855
Virology. 2010 Sep 15;405(1):20-5
pubmed: 20598728
Cell. 1992 Feb 21;68(4):673-82
pubmed: 1739974
J Virol. 2009 Oct;83(19):10275-9
pubmed: 19605473
J Biol Chem. 1996 Aug 30;271(35):21604-13
pubmed: 8702948
Lancet. 1971 Jun 19;1(7712):1253-7
pubmed: 4104714
Methods Mol Med. 2005;119:445-62
pubmed: 16350417
J Virol. 2015 Apr;89(8):4069-79
pubmed: 25653441
J Biol Chem. 1984 May 10;259(9):5809-15
pubmed: 6325450
mBio. 2014 Aug 05;5(4):e01104-14
pubmed: 25096873

Auteurs

Miriam Becker (M)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.

Melissa Dominguez (M)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.

Lilo Greune (L)

Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.
Institute of Infectiology, ZMBE, University of Münster, Münster, Germany.

Laura Soria-Martinez (L)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.
Research Group, FOR2327 ViroCarb, Coordinating University of Tübingen, Tübingen, Germany.

Moritz M Pfleiderer (MM)

Research Group, FOR2327 ViroCarb, Coordinating University of Tübingen, Tübingen, Germany.
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.

Rachel Schowalter (R)

Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Christopher B Buck (CB)

Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Bärbel S Blaum (BS)

Research Group, FOR2327 ViroCarb, Coordinating University of Tübingen, Tübingen, Germany.
Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.

M Alexander Schmidt (MA)

Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.
Institute of Infectiology, ZMBE, University of Münster, Münster, Germany.

Mario Schelhaas (M)

Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany schelhaas@uni-muenster.de.
Cluster of Excellence EXC1003, Cells in Motion, Münster, Germany.
Research Group, FOR2327 ViroCarb, Coordinating University of Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH